A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin-Reference-Cited by-同舟云学术

A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin

Published:2016-10-28 Issue:11 Volume:14 Page:2148-2157
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Belk K. W.¹,Laposata M.²,Craver C.¹³

Affiliation:

1. MedAssets, Inc.; Health Data Analytics; Charlotte NC USA

2. Department of Pathology; University of Texas Medical Branch-Galveston; Galveston TX USA

3. College of Health and Human Services; University of North Carolina-Charlotte; Charlotte NC USA

Funder

Instrumentation Laboratory, Bedford

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13476/fullpdf

Reference25 articles.

1. Heparins: clinical use and laboratory monitoring;Hoffman;Labmedicine,2010

2. High-risk non-ST elevation acute coronary syndrome outcomes in patients treated with unfractionated heparin monitored using anti-Xa concentrations versus activated partial thromboplastin time;Hamilton;Hospital Pharmacy,2013

3. Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time;Cuker;J Thromb Haemost,2009

4. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring;Vandiver;Hospital Practice,1995

5. Discordant aPTT and Anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin;Price;Ann Pharmacother,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline;British Journal of Haematology;2024-09-02

2. Anticoagulation Strategies During ECMO Application;Evolving Therapies and Technologies in Extracorporeal Membrane Oxygenation [Working Title];2024-06-05

3. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice;Seminars in Thrombosis and Hemostasis;2024-05-29

4. Structure comparison and anti-coagulant effects of the glycosaminoglycans from porcine duodenum and jejunum;Food Chemistry;2022-03

5. Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of Geneva;BMJ Open;2022-03